Sfoglia per AUTORE
FIMIANI F
Collezione AOU Novara
Items : 3
Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry. in European journal of preventive cardiology / Eur J Prev Cardiol. 2024 Nov 11;31(15):1806-1816. doi: 10.1093/eurjpc/zwae170.
2024
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara
Merolla A; Iannone FP; Romano A; Dell'Anno R; Vallefuoco G; Passaretti G; Testa C; Cuomo G; Perrone-Filardi P; Paolillo S; Soricelli A; Salvatore M; Prastaro M; Nardi E; Parlati ALM; Buonocore D; Indolfi C; Fontanarosa S; Marzano F; Bilato C; Crisci M; Paloscia L; Brunetti ND; Casu G; De Luca L; Merlini PA; Maloberti A; Quarta R; Polimeni A; et alii...
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology. in Vascular pharmacology / Vascul Pharmacol. 2023 Feb;148:107137. doi: 10.1016/j.vph.2022.107137. Epub 2022 Dec 1.
2023
AOU Novara
AOU Novara
Patti G; Cavallari I; Cesaro A; Gragnano F; Riva L; Fimiani F; Cuccia C; Fresco C; Calabrò P; Leonardi S; Marcucci R; Rubboli A;
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. in International journal of cardiology / Int J Cardiol. 2021 Dec 15;345:7-13. doi: 10.1016/j.ijcard.2021.10.138. Epub 2021 Oct 23.
2021
AOU Novara
AOU Novara
Cesaro A; Gragnano F; Calabrò P; Moscarella E; Santelli F; Fimiani F; Patti G; Cavallari I; Antonucci E; Cirillo P; Pignatelli P; Palareti G; Pelliccia F; Bossone E; Pengo V; Gresele P; Marcucci R;